Inventor · disambiguated record
Cara Baron Casseday
Also filed as: CASSEDAY CARA · CASSEDAY CARA BARON
8 granted patents·4 pending applications·31 citations·filing 2007–2021
83Inventor score
Top patents by PatentIndex Score
12 records- 0190US7915307B2Methods of improving the pharmacokinetics of doxepinSOMAXON PHARMACEUTICALS INC·Filed 2007·Granted Mar 29, 2011·28 cites·24 claims
- 0275US9907780B2Low-dose doxepin formulations and methods of making and using the samePERNIX SLEEP INC·Filed 2016·Granted Mar 6, 2018·1 cites·20 claims
- 0374US2021393567A1Methods Of Improving The Pharmacokinetics Of DoxepinCURRAX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0473US2022110908A1Low-Dose Doxepin Formulations And Methods Of Making And Using The SameCURRAX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0572US9572814B2Methods of improving the pharmacokinetics of doxepinPERNIX SLEEP INC·Filed 2012·Granted Feb 21, 2017·1 cites·14 claims
- 0671US11110074B2Methods of improving the pharmacokinetics of doxepinCURRAX PHARMACEUTICALS LLC·Filed 2020·Granted Sep 7, 2021·0 cites·19 claims
- 0770US9532971B2Low-dose doxepin formulations and methods of making and using the samePERNIX SLEEP INC·Filed 2013·Granted Jan 3, 2017·1 cites·10 claims
- 0869US11096920B2Low-dose doxepin formulations and methods of making and using the sameCURRAX PHARMACEUTICALS LLC·Filed 2020·Granted Aug 24, 2021·0 cites·20 claims
- 0965US10548871B2Low-dose doxepin formulations and methods of making and using the samePERNIX SLEEP INC·Filed 2018·Granted Feb 4, 2020·0 cites·20 claims
- 1063US10653660B2Methods of improving the pharmacokinetics of doxepinPERNIX SLEEP INC·Filed 2017·Granted May 19, 2020·0 cites·19 claims
- 1161US2009074862A1Low-dose doxepin formulations and methods of making and using the sameSCHIOPPI LUIGI·Filed 2008·Application pending·0 cites
- 1252US2011166215A1Methods of improving the pharmacokinetics of doxepinSOMAXON PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →